Research use only. SHDW Research (Shadow Research) compounds are intended strictly for laboratory and in vitro research. Not for human or veterinary consumption, medical use, or diagnostic procedures. Buyers are responsible for lawful handling and local compliance.
CJC-1295 + Ipamorelin is available from SHDW Research (Shadow Research) as a laboratory research compound. Dual-peptide research formulation combining a GHRH analog with a selective ghrelin-receptor agonist.
What is CJC-1295 + Ipamorelin?
CJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog used in endocrine and receptor-signaling research. Ipamorelin is a selective ghrelin receptor agonist commonly studied for GH-secretagogue pathway work. Combined formulations allow laboratories to examine concurrent pathway stimulation under controlled assay designs.
SHDW Research also catalogs related GHRH materials such as CJC with DAC for comparative research purchasing.
Laboratory research angles
- Identity and purity confirmation for in vitro workflows
- Pathway or receptor-related assay design (institution-dependent)
- Comparative studies versus related research peptides
- Documentation requests (COA) for purchasing records
This page does not provide experimental protocols, dosing, administration guidance, or human-use recommendations.
Quality expectations at SHDW Research
CJC-1295 + Ipamorelin listings follow the same Shadow Research / SHDW Research standards: ≥99% purity target, third-party testing support, and research-use-only terms. See our COA & testing standards page.
Related SHDW Research product
View CJC-1295 + Ipamorelin in the shop →
CJC-1295 + Ipamorelin FAQ
Is CJC-1295 + Ipamorelin for human use?
No. It is sold strictly for laboratory / in vitro research.
Does SHDW Research provide a COA for CJC-1295 + Ipamorelin?
COAs are available upon request or with select batches. Contact support with the product name and order number.
Is SHDW Research the same as Shadow Research?
Yes. SHDW is the brand abbreviation for Shadow Research.